You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 262 No. 4, July 28, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (100)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Association of Mitral Valve Prolapse and Systemic Abnormalities of Connective Tissue

A Phenotypic Continuum

Marshall J. Glesby, MD; Reed E. Pyeritz, MD, PhD

JAMA. 1989;262(4):523-528.


Abstract

More than half of all patients evaluated in our clinic for the possible diagnosis of a heritable disorder of connective tissue could not be classified in the current nosology, yet they had considerable clinical evidence of a systemic defect of the extracellular matrix. As a group, these patients share many manifestations of the Marfan syndrome including long limbs, deformity of the thoracic cage, striae atrophicae, mitral valve prolapse, and mild dilatation of the aortic root. Clinical clustering did not emerge when patients were stratified by mitral valve prolapse or aortic dilatation. The clinical phenotype of patients with mitral valve prolapse constitutes a continuum, from Marfan syndrome at one extreme to isolated mitral valve prolapse due to myxomatous proliferation of the valve leaflets. In the absence of biochemical or DNA markers, discerning whether a patient with mitral valve prolapse and mild aortic root dilatation (in the absence of ectopia lentis or a family history) has Marfan syndrome, or another heritable disorder of connective tissue, will continue to be a clinical challenge. Until subclassification based on refined clinical, genetic, and laboratory investigations is possible, the patients we describe are best seen as having an "overlap" heritable connective-tissue disorder. We suggest the acronym "MASS phenotype" to emphasize involvement of the mitral valve, aorta, skeleton, and skin.

(JAMA. 1989;262:523-528)



Author Affiliations

From the Center for Medical Genetics, Departments of Medicine and Pediatrics, The Johns Hopkins Medical Institutions, Baltimore, Md.


Footnotes

Reprint requests to Blalock 1012, The Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21205 (Dr Pyeritz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Marfan Syndrome
Shirley and Sponseller
J Am Acad Orthop Surg 2009;17:572-581.
ABSTRACT | FULL TEXT  

Pulmonary Nontuberculous Mycobacterial Disease: Prospective Study of a Distinct Preexisting Syndrome
Kim et al.
Am. J. Respir. Crit. Care Med. 2008;178:1066-1074.
ABSTRACT | FULL TEXT  

Medical Management of Marfan Syndrome
Keane and Pyeritz
Circulation 2008;117:2802-2813.
FULL TEXT  

New Locus for Autosomal Dominant Mitral Valve Prolapse on Chromosome 13: Clinical Insights From Genetic Studies
Nesta et al.
Circulation 2005;112:2022-2030.
ABSTRACT | FULL TEXT  

Picture of the Month--Diagnosis
Arch Pediatr Adolesc Med 2005;159:722-723.
FULL TEXT  

Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy
Lucioli et al.
Neurology 2005;64:1931-1937.
ABSTRACT | FULL TEXT  

Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome
Maron et al.
J Am Coll Cardiol 2005;45:1340-1345.
FULL TEXT  

Fibrillin and other matrix proteins in mitral valve prolapse syndrome
Nasuti et al.
Ann. Thorac. Surg. 2004;77:532-536.
ABSTRACT | FULL TEXT  

Aortic Dissection: New Frontiers in Diagnosis and Management: Part I: From Etiology to Diagnostic Strategies
Nienaber and Eagle
Circulation 2003;108:628-635.
FULL TEXT  

Activated Interstitial Myofibroblasts Express Catabolic Enzymes and Mediate Matrix Remodeling in Myxomatous Heart Valves
Rabkin et al.
Circulation 2001;104:2525-2532.
ABSTRACT | FULL TEXT  

Diagnosis and management of aortic dissection: Task Force on Aortic Dissection, European Society of Cardiology
Erbel et al.
Eur Heart J 2001;22:1642-1681.
 

Mitral valve prolapse in the dog: a model of mitral valve prolapse in man
Pedersen and Haggstrom
Cardiovasc Res 2000;47:234-243.
FULL TEXT  

Clinical characteristics of a familial inherited myxomatous valvular dystrophy mapped to Xq28
Trochu et al.
J Am Coll Cardiol 2000;35:1890-1897.
ABSTRACT | FULL TEXT  

Structure, Chromosomal Localization, and Promoter Analysis of the Human Elastin Microfibril Interfase Located proteIN (EMILIN) Gene
Doliana et al.
J. Biol. Chem. 2000;275:785-792.
ABSTRACT | FULL TEXT  

Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome : A Statement for Healthcare Professionals From the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association
Maron et al.
Circulation 1998;98:1460-1471.
FULL TEXT  

A Molecular Approach to the Stratification of Cardiovascular Risk in Families with Marfan's Syndrome
Pereira et al.
NEJM 1994;331:148-153.
ABSTRACT | FULL TEXT  

Striae and Systemic Abnormalities of Connective Tissue
Pottkotter
JAMA 1989;262:3132-3132.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.